U. Bogdahn

First name

U.

Last name

Bogdahn

Seliger, C., Meier, C. R., Jick, S. S., Uhl, M., Bogdahn, U., Hau, P., & Leitzmann, M. F. (2016). Use of cardiac glycosides and risk of glioma. J Neurooncol. http://doi.org/10.1007/s11060-015-2036-2

View

Seliger, C., Meier, C. R., Becker, C., Jick, S. S., Bogdahn, U., Hau, P., & Leitzmann, M. F. (2016). Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma. PLoS One. http://doi.org/10.1371/journal.pone.0149293

View

Seliger, C., Meier, C. R., Becker, C., Jick, S. S., Bogdahn, U., Hau, P., & Leitzmann, M. F. (2016). Statin use and risk of glioma: population-based case-control analysis. Eur J Epidemiol. http://doi.org/10.1007/s10654-016-0145-7

View

Seliger, C., Ricci, C., Meier, C. R., Bodmer, M., Jick, S. S., Bogdahn, U., et al. (2016). Diabetes, use of antidiabetic drugs, and the risk of glioma. Neuro Oncol. http://doi.org/10.1093/neuonc/nov100

View

Seliger, C., Meier, C. R., Becker, C., Jick, S. S., Proescholdt, M., Bogdahn, U., et al. (2017). Metabolic syndrome in relation to risk of meningioma. Oncotarget. http://doi.org/10.18632/oncotarget.13667

View

Seliger, C., Meier, C. R., Becker, C., Jick, S. S., Proescholdt, M., Bogdahn, U., et al. (2017). Diabetes, use of metformin, and the risk of meningioma. PLoS One. http://doi.org/10.1371/journal.pone.0181089

View